These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 25724159)
1. Development of a Control Strategy for Benzene Impurity in HPMCAS-Stabilized Spray-Dried Dispersion Drug Products Using a Science-Based and Risk-Based Approach. Yue H; Nicholson SJ; Young JD; Hsieh D; Ketner RJ; Hall RG; Sackett J; Banks EC; Castoro JA; Randazzo ME Pharm Res; 2015 Aug; 32(8):2636-48. PubMed ID: 25724159 [TBL] [Abstract][Full Text] [Related]
2. The secondary drying and the fate of organic solvents for spray dried dispersion drug product. Hsieh DS; Yue H; Nicholson SJ; Roberts D; Schild R; Gamble JF; Lindrud M Pharm Res; 2015 May; 32(5):1804-16. PubMed ID: 25515491 [TBL] [Abstract][Full Text] [Related]
4. Determination of residual acetone and acetone related impurities in drug product intermediates prepared as Spray Dried Dispersions (SDD) using gas chromatography with headspace autosampling (GCHS). Quirk E; Doggett A; Bretnall A J Pharm Biomed Anal; 2014 Aug; 96():37-44. PubMed ID: 24721204 [TBL] [Abstract][Full Text] [Related]
5. Mechanistic Study of Belinostat Oral Absorption From Spray-Dried Dispersions. Stewart A; Yates I; Mudie D; Pivette P; Goodwin A; Sarmiento A; Winter M; Morgen M; Vodak D J Pharm Sci; 2019 Jan; 108(1):326-336. PubMed ID: 30300620 [TBL] [Abstract][Full Text] [Related]
6. Approaches to Understanding the Solution-State Organization of Spray-Dried Dispersion Feed Solutions and Its Translation to the Solid State. Defrese MK; Farmer MA; Long Y; Timmerman LR; Bae Y; Marsac PJ Mol Pharm; 2020 Dec; 17(12):4548-4563. PubMed ID: 32965120 [TBL] [Abstract][Full Text] [Related]
7. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine. Mahmah O; Tabbakh R; Kelly A; Paradkar A J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426 [TBL] [Abstract][Full Text] [Related]
8. Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges. Li J; Patel D; Wang G AAPS J; 2017 Mar; 19(2):321-333. PubMed ID: 27896684 [TBL] [Abstract][Full Text] [Related]
10. Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: case example fenofibrate. Hugo M; Kunath K; Dressman J Drug Dev Ind Pharm; 2013 Feb; 39(2):402-12. PubMed ID: 22591213 [TBL] [Abstract][Full Text] [Related]
11. Surface Enrichment and Depletion of the Active Ingredient in Spray Dried Amorphous Solid Dispersions. Chen Z; Yang K; Huang C; Zhu A; Yu L; Qian F Pharm Res; 2018 Jan; 35(2):38. PubMed ID: 29380074 [TBL] [Abstract][Full Text] [Related]
12. Impact of formulation excipients on the thermal, mechanical, and electrokinetic properties of hydroxypropyl methylcellulose acetate succinate (HPMCAS). Deshpande TM; Quadir A; Obara S; Hoag SW Int J Pharm; 2018 May; 542(1-2):132-141. PubMed ID: 29458211 [TBL] [Abstract][Full Text] [Related]
13. The effects of spray drying, HPMCAS grade, and compression speed on the compaction properties of itraconazole-HPMCAS spray dried dispersions. Honick M; Das S; Hoag SW; Muller FX; Alayoubi A; Feng X; Zidan A; Ashraf M; Polli JE Eur J Pharm Sci; 2020 Dec; 155():105556. PubMed ID: 32946956 [TBL] [Abstract][Full Text] [Related]
14. Modelling drug degradation in a spray dried polymer dispersion using a modified Arrhenius equation. Patterson A; Ferreira AP; Banks E; Skeene K; Clarke G; Nicholson S; Rawlinson-Malone C Int J Pharm; 2015 Jan; 478(1):348-360. PubMed ID: 25450477 [TBL] [Abstract][Full Text] [Related]
16. Effects of spray drying process parameters on the solubility behavior and physical stability of solid dispersions prepared using a laboratory-scale spray dryer. Kojima Y; Ohta T; Shiraki K; Takano R; Maeda H; Ogawa Y Drug Dev Ind Pharm; 2013 Sep; 39(9):1484-93. PubMed ID: 22670826 [TBL] [Abstract][Full Text] [Related]
17. Optimization of the Büchi B-90 spray drying process using central composite design for preparation of solid dispersions. Gu B; Linehan B; Tseng YC Int J Pharm; 2015 Aug; 491(1-2):208-17. PubMed ID: 26070248 [TBL] [Abstract][Full Text] [Related]
18. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions. Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988 [TBL] [Abstract][Full Text] [Related]
19. Solution-state polymer assemblies influence BCS class II drug dissolution and supersaturation maintenance. Dalsin MC; Tale S; Reineke TM Biomacromolecules; 2014 Feb; 15(2):500-11. PubMed ID: 24328187 [TBL] [Abstract][Full Text] [Related]